Show simple item record

dc.contributor.authorTodryk, Stephen M
dc.contributor.authorBassendine, Margaret F
dc.contributor.authorBridge, Simon H
dc.date.accessioned2021-03-01T01:38:00Z
dc.date.available2021-03-01T01:38:00Z
dc.date.issued2021
dc.identifier.issn2076-393X
dc.identifier.doi10.3390/vaccines9020114
dc.identifier.urihttp://hdl.handle.net/10072/402685
dc.description.abstractThe impactful discovery and subsequent characterisation of hepatitis C virus (HCV), an RNA virus of the flavivirus family, led to the awarding of the 2020 Nobel Prize in Physiology or Medicine to Harvey J. Alter, Michael Houghton and Charles M. Rice [...].
dc.languageeng
dc.publisherMDPI AG
dc.relation.ispartofpagefrom114
dc.relation.ispartofissue2
dc.relation.ispartofjournalVaccines
dc.relation.ispartofvolume9
dc.subject.fieldofresearchMicrobiology
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchcode3107
dc.subject.fieldofresearchcode3204
dc.titleRevisiting the Elusive Hepatitis C Vaccine
dc.typeJournal article
dc.type.descriptionC2 - Articles (Other)
dcterms.bibliographicCitationTodryk, SM; Bassendine, MF; Bridge, SH, Revisiting the Elusive Hepatitis C Vaccine., Vaccines, 2021, 9 (2), pp. 114
dcterms.dateAccepted2021-01-27
dcterms.licensehttp://creativecommons.org/licenses/by/4.0/
dc.date.updated2021-03-01T01:22:37Z
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
gro.hasfulltextFull Text
gro.griffith.authorTodryk, Stephen M.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record